Isarna Therapeutics

Develop selective TGF-β inhibitors to effectively treat ophthalmic diseases.

HQ location

Munich, Germany

Website

isarna-therapeutics.com

Launch date

1998

Employees

Enterprise value

$30—46m

Company register number

HRB 211121 (München)

https://www.linkedin.com/company/isarna-therapeutics-gmbh

Authorizing premium user...